Initiation of mineralocorticoid receptor antagonists in patients with cardiorenal diseases: potassium changes, hyperkalaemia risk and discontinuation in the CaRe study
10 May 2026 (16:20 - 16:30)
Organised by: 
About the speaker
Duke Clinical Research Institute, Durham (United States of America)
5 More presentations in this session
Professor S. Greene (Durham, US)
Doctor B. Resende (Coimbra, PT)
Doctor R. Aggarwal (Boston, US)
Assistant Professor M. Ruppert (Boston, US)
Access the full session
The Event
Heart Failure 2026
10 May 2026
16:20 CET
You may be interested in
Congress Presentation
Congress Session
